These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10618372)

  • 1. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.
    Gooptu B; Hazes B; Chang WS; Dafforn TR; Carrell RW; Read RJ; Lomas DA
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):67-72. PubMed ID: 10618372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
    Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
    J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleation of alpha 1-antichymotrypsin polymerization.
    Crowther DC; Serpell LC; Dafforn TR; Gooptu B; Lomas DA
    Biochemistry; 2003 Mar; 42(8):2355-63. PubMed ID: 12600202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.
    Wei A; Rubin H; Cooperman BS; Christianson DW
    Nat Struct Biol; 1994 Apr; 1(4):251-8. PubMed ID: 7656054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of the covalent chymotrypsin.antichymotrypsin complex involves no large-scale movement of the enzyme.
    O'Malley KM; Cooperman BS
    J Biol Chem; 2001 Mar; 276(9):6631-9. PubMed ID: 11027695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema.
    Chang WS; Lomas DA
    J Biol Chem; 1998 Feb; 273(6):3695-701. PubMed ID: 9452500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.
    Elliott PR; Abrahams JP; Lomas DA
    J Mol Biol; 1998 Jan; 275(3):419-25. PubMed ID: 9466920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory conformation of the reactive loop of alpha 1-antitrypsin.
    Elliott PR; Lomas DA; Carrell RW; Abrahams JP
    Nat Struct Biol; 1996 Aug; 3(8):676-81. PubMed ID: 8756325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin.
    Plotnick MI; Rubin H; Schechter NM
    J Biol Chem; 2002 Aug; 277(33):29927-35. PubMed ID: 12055188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2.6 A structure of a serpin polymer and implications for conformational disease.
    Huntington JA; Pannu NS; Hazes B; Read RJ; Lomas DA; Carrell RW
    J Mol Biol; 1999 Oct; 293(3):449-55. PubMed ID: 10543942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia.
    Lomas DA; Lourbakos A; Cumming SA; Belorgey D
    Biochem Soc Trans; 2002 Apr; 30(2):89-92. PubMed ID: 12023831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antichymotrypsin interaction with chymotrypsin. Intermediates on the way to inhibited complex formation.
    Luo Y; Zhou Y; Cooperman BS
    J Biol Chem; 1999 Jun; 274(25):17733-41. PubMed ID: 10364215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease.
    Faber JP; Poller W; Olek K; Baumann U; Carlson J; Lindmark B; Eriksson S
    J Hepatol; 1993 Jul; 18(3):313-21. PubMed ID: 8228125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-antichymotrypsin.
    Kalsheker NA
    Int J Biochem Cell Biol; 1996 Sep; 28(9):961-4. PubMed ID: 8930118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural basis for loop C-sheet polymerization in serpins.
    Zhang Q; Law RH; Bottomley SP; Whisstock JC; Buckle AM
    J Mol Biol; 2008 Mar; 376(5):1348-59. PubMed ID: 18234218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of the reactive form of plasminogen activator inhibitor-1.
    Aertgeerts K; De Bondt HL; De Ranter C; Declerck PJ
    J Struct Biol; 1994; 113(3):239-45. PubMed ID: 7734247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the structural basis of alpha 1-antitrypsin deficiency.
    Lomas DA
    QJM; 1996 Nov; 89(11):807-12. PubMed ID: 8977959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis.
    Mahadeva R; Dafforn TR; Carrell RW; Lomas DA
    J Biol Chem; 2002 Mar; 277(9):6771-4. PubMed ID: 11773044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.